Founded in January 2008, Elevation Pharmaceuticals has raised more than $60 million from premiere healthcare and pharmaceutical-focused venture capital investors.
 Canaan Partners |
 Care Capital |
 TPG Biotech |
 Mesa Verde Venture Partners |
 Novo Ventures |